Purpose The pharmacology, pharmacokinetics, efficacy, and safety of apixaban are reviewed ... the need for anticoagulation monitoring or dosage adjustment. Apixaban has multiple elimination ...

One group from each was given apixaban, dubbed TAH3311, with the other two given an Eliquis tablet. Results found the maximum plasma concentration in patients dosed with TAH3311 was equivalent to ...

With the emergence and approval of other new oral anticoagulants such as dabigatran and rivaroxaban, the role of and place in therapy for all of these new agents will have to be clearly delineated.